iiinova — where your digital self keeps evolving

Reposted by Mac4Me

EACR - European Association for Cancer Research @helloeacr.bsky.social · 03/09/2026

Submit your abstracts for the EACR conference 'Systems-level engineering of T-cell specificity' by 19 Oct 2026! This conference will bring together basic, computational, translational, and clinical scientists interested in understanding and engineering T-cell specificity. eacr.org/conference/t...

022

Mac4Me @mac4me.bsky.social · 24/09/2026

Today is #WorldCancerResearchDay! 🔬 Under the global theme "Advancing Cancer Research Together", we remember a fact: Behind every treatment, there’s research. 🧵👇

100

Reposted by Mac4Me

DBMR University Bern @dbmr-unibe.bsky.social · 23/06/2026

🔬 The #MSCA @mac4me.bsky.social network just wrapped its second consortium meeting & doctoral training! Five days of technical training, research collaboration, PPI, and professional communication. Great to see @marubin1.bsky.social & Marine Cullier contributing!

012

Mac4Me @mac4me.bsky.social · 15/02/2026

🎗️ 15th of February is #InternationalChildhoodCancerDay. At #Mac4Me, our ultimate goal is to improve treatment options for metastatic #Neuroblastoma. We research: 🔹 3D printing miniature brain models to stop tumor survival. 🔹 Chips that mimic blood flow to block cancer from spreading.

010

Mac4Me @mac4me.bsky.social · 11/02/2026

Research and innovation aren’t abstract. They are driven by people. On this International Day of Women & Girls in Science, we highlight the daily labor of our diverse network.

111

Reposted by Mac4Me

Christine Hodgdon @christeeny513.bsky.social · 05/02/2026

Every day is #WorldCancerDay for patient, but I’m proud to work with researchers at @mac4me.bsky.social to center patient voices and build cancer care that reflects our unique needs. @graspcancer.bsky.social #WorldCancerDay #UnitedByUnique

022

Mac4Me @mac4me.bsky.social · 04/02/2026

Today is #WorldCancerDay 2026. This year's #UnitedbyUnique initiative calls for "people-centered care"—a shift from treating just the disease to treating the unique person behind it. Mac4Me translates this vision into research for metastatic neuroblastoma, prostate, and breast cancers. 🧬

143

Reposted by Mac4Me

EU Council @consilium.europa.eu · 04/02/2026

On #WorldCancerDay, we stand with cancer warriors, survivors, and their families. The EU is working to improve access to: 🚫 Prevention 🔍 Diagnosis 💊 Treatment 🏥 Care More info 👉 link.europa.eu/P4kWyr

02911

Reposted by Mac4Me

Institute for Molecular Medicine Finland (FIMM) @fimm-uh.bsky.social · 22/01/2026

Mac4Me is a European doctoral network aiming to provide new treatment options for metastatic neuroblastoma, prostate and breast tumours. Meet Sidney van der Zande, one of the 18 @mac4me.bsky.social doctoral candidates, supervised by Teijo Pellinen at FIMM: 📽️ www.youtube.com/watch?v=ficq...

youtube.com

Sidney van der Zande

YouTube video by Mac4Me

021

Mac4Me @mac4me.bsky.social · 02/01/2026

🥂 Happy New Year from Mac4Me! We’re celebrating the power of international collaboration in the fight against metastatic cancer. Looking forward to a year of bold questions and shared milestones. Here’s to a year of discovery, collaboration, and scientific progress!! 🚀

000

Mac4Me @mac4me.bsky.social · 19/12/2025

🚀 The first Mac4Me Newsletter is here! Catch up on our latest research updates in metastatic neuroblastoma, prostate, and breast cancer. 📖 Read the first issue: mac4me.eu/newsletter-a... 📩 Subscribe: mac4me.us22.list-manage.com/subscribe?u=...

000

Mac4Me @mac4me.bsky.social · 19/11/2025

During #ScienceWeek we introduced our Doctoral Candidates (DC) through short videos! 🔬🎬 🔗 Watch them on our YouTube Channel: www.youtube.com/watch?v=ward... Get to know our DCs and learn about their work in metastatic cancer research! ✨

032

Mac4Me @mac4me.bsky.social · 29/10/2025

📢 The Mac4Me Doctoral Network is opening up some of our specialized online training modules (originally for our doctoral candidates) to the public! 🔬 We invite all interested researchers, students, and professionals to join us! 🗓️ Check the program and register here: mac4me.eu/online-semin...

mac4me.eu

Online seminar series November 2025 - Mac4me

The European doctoral network Mac4Me (Macrophage Targets for Metastatic Treatment) launched with a virtual meeting on 12 February 2025. Simultaneously, it also launched its digital and social media pr...

041

Mac4Me @mac4me.bsky.social · 22/10/2025

"Who Owns Our Knowledge?" is the theme for Open Access (OA) Week 💡 (www.openaccessweek.org) This is the right question for a time of disruption. Who controls the research produced by the community? Our doctoral network aligns with Open Science.

openaccessweek.org

International Open Access Week

International Open Access Week is held annually to inspire global momentum toward the open sharing of knowledge in order to address important social issues affecting people around the world. Open Acce...

120

Mac4Me @mac4me.bsky.social · 19/10/2025

In the context of Breast Cancer Awareness Month 🎀, October 19th marks the International Day against Breast Cancer🎗. It is a moment to stand in solidarity with the millions worldwide affected by this disease. We acknowledge the resilience of patients and those navigating life after diagnosis.

120

Mac4Me @mac4me.bsky.social · 13/10/2025

Metastatic disease affects 20-30% of early breast cancer patients. This is the frontier where we need to focus.🎯 Mac4Me’s goal is to help transform metastatic breast cancer from a typically terminal condition into a chronic or potentially curable one. #MetastaticBreastCancerAwarenessDay

155

Mac4Me @mac4me.bsky.social · 24/09/2025

Today, September 24th, is #WorldCancerResearchDay. It is a yearly momentum to raise awareness and commitment for cancer research. This day also serves as a reminder that progress depends on collaboration.

165

Reposted by Mac4Me

Stem Cell Glycobiology Lab @merrylabnotts.bsky.social · 26/06/2025

Hugely excited to meet the @mac4me.bsky.social team in Rotterdam for our kick-off meeting. Here with @peptimatrix.bsky.social and a whole interdisciplinary team ’opening new doors in cancer immunotherapy’ www.mac4me.eu

The (current) Nottingham and Peptimatrix team. A group of men and women smiling on a deck by the river

043

Reposted by Mac4Me

PeptiMatrix @peptimatrix.bsky.social · 08/07/2025

The @mac4me.bsky.social project officially kicked off in Rotterdam on 25-26 June! It was great to connect with partners in person and meet our DC, Elena Montero Bragado. 🔗 Read the Full story: www.peptimatrix.com/post/mac4me-... #Mac4Me #HorizonEurope #CancerResearch #3DCellCulture #MSCA

peptimatrix.com

Mac4Me Project Kicks off in Rotterdam

Mac4Me project kicks off with a meeting in Rotterdam and the first doctoral training session.

021

Mac4Me @mac4me.bsky.social · 08/07/2025

🎊 The Mac4Me Doctoral Network officially kicked off two weeks ago (25-26 June)! 🎉 Our core partners gathered to set the stage for four years of research. We're excited for what's ahead!

110

Mac4Me @mac4me.bsky.social · 18/04/2025

On European Patients' Rights Day, we remember that patients deserve effective treatment and clear information. Mac4Me's research aims to personalise immunotherapies for metastatic cancers, better predict treatment outcomes and keep people informed all the way through. Learn more at mac4me.eu

mac4me.eu

Home - Mac4me

Mac4me is dedicated to advancing metastatic neuroblastoma treatment through innovative research and immunotherapy solutions

030

Mac4Me @mac4me.bsky.social · 08/03/2025

On this #WomensDay, we recognise the impact of breast cancer on women around the world. Today, we remark the dedication of female researchers who are advancing metastasis understanding and the vital role of women's perspectives in shaping more effective and inclusive cancer care and research.

021

Mac4Me @mac4me.bsky.social · 13/02/2025

🎉 Yesterday we launched online Mac4Me - an European doctoral network studying Macrophage Targets for Metastatic Treatment! We are investigating neuroblastoma, breast, and prostate cancers - three tumor types that share metastatic spread to brain, bone, and liver.

1153